OverStitch™ receives European CE Mark, will begin shipping product this month
Designation based on venture backing, scientific and technological impact, quality and experience of team
Apollo Endosurgery, Inc. today announced that Richard J. Meelia, former CEO and Chairman of Covidien plc, will be joining the company’s Board of Directors.
Proceeds to Support Launch of a New Generation of Flexible Surgery Tools
SuMO System Allows Physicians to Perform Scarless Surgery to Remove Large Flat Pre-Cancerous Lesions During Colonoscopies and Upper Endoscopies
Apollo Endosurgery®, Inc. announced today that it has signed a Memorandum of Understanding (MOU) with Apollo Hospitals Group, one of the largest healthcare networks in Asia, to promote the adoption of incisionless bariatric procedures with flexible surgery tools in India
OverStitch™ Endoscopic Suturing System Allowed Doctors to Close Large Wound in Colon Using Incisionless Approach without Laparoscopic Assistance
Apollo Endosurgery, Inc., a leading company in the emerging field of flexible surgery, announced today the appointment of Michael J. Doty as Chief Financial Officer (CFO).
Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient’s mouth.
Apollo Endosurgery, Inc. announced preliminary results from their GEMINI suturing registry. These results confirm the procedure enabling capability of their newly-launched OverStitch™ Endoscopic Suturing System in a variety of clinical cases in the esophagus, stomach and colon.
Apollo Endosurgery, Inc. announced that their newlylaunched OverStitch™ Endoscopic Suturing System has recently been employed in several, first-in-human cases.
Apollo Endosurgery, Inc. announced completion of the first clinical case involving its FlexShears™ Endoscopic Scissors. The new device was used to cut and remove an obstructing eroded suture from the patient’s GI tract in a procedure that embodies the Apollo vision of improving patient care with flexible surgery.
Apollo Endosurgery announced today that the Company received notice of a $5 million award from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). Apollo was one of only three companies recommended for the inaugural commercialization awards. CPRIT was established to expedite innovation and commercialization in the area of cancer research and to enhance access to evidence-based prevention programs and services throughout the State. Acceptance of the award is subject to the completion of final due diligence and contract negotiations.
Apollo Endosurgery, Inc. has just concluded a successful participation at the 12th World Congress of Endoscopic Surgery, where they previewed two new products: The OverStitch™ Endoscopic Suturing System and the FlexShears™ Endoscopic Scissors.